SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Prevail Therapeutics Q1 EPS $(0.560) Up From $(1.730) YoY

Prevail Therapeutics (NASDAQ:PRVL) reported quarterly losses of $(0.560) per share. This is a 67.63 percent increase over losses of $(1.730) per share from the same period last year.

Benzinga · 05/14/2020 11:16

Prevail Therapeutics (NASDAQ:PRVL) reported quarterly losses of $(0.560) per share. This is a 67.63 percent increase over losses of $(1.730) per share from the same period last year.